Clausen, Lene
Voutsinos, Vasileios https://orcid.org/0000-0002-0911-3648
Cagiada, Matteo
Johansson, Kristoffer E. https://orcid.org/0000-0001-6054-0461
Grønbæk-Thygesen, Martin
Nariya, Snehal
Powell, Rachel L. https://orcid.org/0000-0003-4791-6692
Have, Magnus K. N.
Oestergaard, Vibe H. https://orcid.org/0000-0002-1633-0560
Stein, Amelie https://orcid.org/0000-0002-5862-1681
Fowler, Douglas M. https://orcid.org/0000-0001-7614-1713
Lindorff-Larsen, Kresten https://orcid.org/0000-0002-4750-6039
Hartmann-Petersen, Rasmus https://orcid.org/0000-0002-4155-7791
Funding for this research was provided by:
Novo Nordisk Fonden (PRISM)
Novo Nordisk Fonden (NNF21OC0071057)
Novo Nordisk Fonden (PRISM)
Novo Nordisk Fonden (PRISM)
Novo Nordisk Fonden (PRISM)
Det Frie Forskningsråd (https://doi.org/10.46540/2032-00007B)
Lundbeckfonden (R249-2017-510)
Lundbeckfonden (R249-2017-510)
Lundbeckfonden (R272-2017-452)
Lundbeckfonden (R209-2015-3283)
Article History
Received: 5 July 2023
Accepted: 1 February 2024
First Online: 20 February 2024
Competing interests
: K.L.-L. holds stock options in and is a consultant for Peptone Ltd. The remaining authors declare no competing interest.